Dialysis Clinic, Inc., North Brunswick Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2010
NCT01148745
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

DCI North Brunswick

Active Ingredients

Drugs in Phase 4 Trials (1)

ferumoxytol (feraheme) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia, Iron-Deficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1